4 Midcap Accelerating Profit Stocks to Watch for Future Multibagger Potential: Federal Bank, Oil India, Sona BLW and Ajanta Pharma
- October 26, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Federal Bank Rs 340.90. Oil India Rs 447.85. Sona BLW Rs 752.85. Ajanta Pharma Rs 3,283.90. Market caps from Rs 41,525 crore to Rs 83,333 crore. Data as of 23 Oct 2026.
Quick Answer
Federal Bank, Oil India, Sona BLW and Ajanta Pharma are the 4 picks in this accelerating profit stocks watchlist, with market caps between Rs 41,525 crore and Rs 83,333 crore. Federal Bank stands out for the fastest profit growth, 22.90% a year since FY22, while Oil India offers the strongest latest-quarter profit growth at 96.77%. PE ratios run from 7.63 to 72.68, so compare each one with its industry PE before investing. All figures are as of 23 October 2026.
Accelerating profit stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Federal Bank, Oil India, Sona BLW and Ajanta Pharma meet that test, with market caps from Rs 41,525 crore to Rs 83,333 crore and Federal Bank offering the fastest profit growth, 22.90% a year since FY22. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 profit growth below 15 per cent and latest quarter profit growth of at least 30 per cent, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and FY26 profit growth below 15 per cent and latest quarter profit growth of at least 30 per cent, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening accelerating profit stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 23 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Accelerating Profit Stocks and Why Do They Attract Multibagger Interest?
Accelerating profit stocks are shares of mid sized companies where the latest quarter grew much faster than the full year. The four here cover private banking, oil and gas, auto components and pharmaceuticals.
A quarter that beats the year points to improving momentum. For accelerating profit stocks, both FY26 and the latest quarter showed growth. For accelerating profit stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of accelerating profit stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for accelerating profit stocks before you decide.
Accelerating Profit Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 23 October 2026. Oil India has the lowest PE of the group at 7.63, while Ajanta Pharma posts the highest return on equity at 23.33%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Federal Bank | 340.90 | 83,333 | 15.47 | 11.94 | 12.60% | 2.02 | 211.52 to 371.70 |
| Oil India | 447.85 | 72,750 | 7.63 | 7.16 | 11.41% | 1.25 | 395.60 to 531.00 |
| Sona BLW Precision Forgings | 752.85 | 49,859 | 72.68 | 37.33 | 10.70% | 8.33 | 434.40 to 844.00 |
| Ajanta Pharma | 3,283.90 | 41,525 | 36.59 | 36.35 | 23.33% | 9.17 | 2,380.20 to 3,796.00 |
Federal Bank: 22.90% Profit CAGR Since FY22
Federal Bank is a Kerala-based private sector bank with a strong NRI deposit base and a growing retail, small business and digital franchise. It reported FY26 total income of Rs 34,272.42 crore, up 7.00% year on year, and net profit of Rs 4,483.38 crore, up 6.71%. Net profit has compounded at 22.90% a year since FY22, while total income has grown 20.05% a year.
In the September 2026 quarter, total income rose 19.01% to Rs 9,903.41 crore and net profit grew 53.42% to Rs 1,564.06 crore. The share price has gained 259.57% over five years and 57.58% over the past year. Domestic institutions raised their holding from 48.17% in June 2025 to 49.28% in June 2026. The stock trades at a PE of 15.47 against an industry PE of 11.94, with a return on equity of 12.60%.
Oil India: Quarterly Profit Up 96.77%
Oil India is a government-owned oil and gas exploration and production company with operations in Assam, Rajasthan and overseas blocks. It reported FY26 revenue of Rs 35,877.28 crore, up 4.97% year on year, and net profit of Rs 7,550.67 crore, up 7.26%. Revenue has compounded at 7.32% a year since FY22. Operating margin was 36.43% in FY26.
The stock trades at a PE of 7.63 against an industry PE of 7.16. The dividend yield is 2.57%. In the June 2026 quarter, revenue rose 46.98% to Rs 13,236.10 crore and net profit grew 96.77% to Rs 4,026.83 crore. The share price has gained 183.64% over five years. Domestic institutions raised their holding from 18.41% in June 2025 to 20.14% in June 2026.
Sona BLW: Revenue Up 24.19% in FY26
Sona BLW makes differential gears, motors and drive systems for electric and conventional vehicles for customers around the world. It reported FY26 revenue of Rs 4,572.11 crore, up 24.19% year on year, and net profit of Rs 629.19 crore, up 4.92%. Net profit has compounded at 14.86% a year since FY22, while revenue has grown 20.75% a year. Operating margin was 25.91% in FY26. The debt-to-equity ratio is 0.07, which keeps interest costs low.
In the June 2026 quarter, revenue rose 49.27% to Rs 1,336.07 crore and net profit grew 46.67% to Rs 178.51 crore. The share price is up 70.74% over the past year. Domestic institutions raised their holding from 34.59% in June 2025 to 41.61% in June 2026. The stock trades at a PE of 72.68 against an industry PE of 37.33.
Ajanta Pharma: Return on Equity of 23.33%
Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 36.59 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.
Accelerating Profit Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these accelerating profit stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Total Income (Rs Cr) | Net Profit (Rs Cr) | Income Growth (YoY) | 4-Year Income CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| Federal Bank | 34,272.42 | 4,483.38 | 7.00% | 20.05% | 22.90% |
| Oil India | 35,877.28 | 7,550.67 | 4.97% | 7.32% | 2.96% |
| Sona BLW | 4,572.11 | 629.19 | 24.19% | 20.75% | 14.86% |
| Ajanta Pharma | 5,624.93 | 1,056 | 18.60% | 12.94% | 10.33% |
Check the Univest Screener for live data on these accelerating profit stocks
Institutional Holding in Federal Bank, Oil India, Sona BLW and Ajanta Pharma
Institutional holding shows who is backing these accelerating profit stocks alongside the promoter. The table uses the latest reported quarter for each. Federal Bank has the deepest institutional backing, with FII and DII together holding 76.99% as of June 2026. Domestic institutions increased their holding over the past year in Federal Bank (from 48.17% to 49.28%), Oil India (from 18.41% to 20.14%), Sona BLW (from 34.59% to 41.61%) and Ajanta Pharma (from 17.90% to 21.94%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Federal Bank | Nil | 27.71% | 49.28% | 23.01% | June 2026 |
| Oil India | 56.66% | 7.28% | 20.14% | 15.93% | June 2026 |
| Sona BLW | 28.01% | 23.61% | 41.61% | 6.77% | June 2026 |
| Ajanta Pharma | 63.47% | 7.63% | 21.94% | 6.96% | September 2026 |
Risks to Weigh in Accelerating Profit Stocks
Being careful with accelerating profit stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Sona BLW trades at a PE of 72.68 against an industry PE of 37.33, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Accelerating Profit Stocks
Picking from accelerating profit stocks comes down to four checks, applied in order.
- Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
- Compare each PE with the industry PE (7.16 to 37.33) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Federal Bank, Oil India, Sona BLW and Ajanta Pharma live prices.
Conclusion
Among accelerating profit stocks, Federal Bank stands out for the fastest profit growth, 22.90% a year since FY22, Oil India for the strongest latest-quarter profit growth at 96.77%, Sona BLW for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.07 and Ajanta Pharma for the highest return on equity at 23.33%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing accelerating profit stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Accelerating Profit Stocks to Watch
Which are the best accelerating profit stocks to watch for multibagger potential?
Ans. Federal Bank, Oil India, Sona BLW and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 83,333 crore, Rs 72,750 crore, Rs 49,859 crore and Rs 41,525 crore respectively. Federal Bank is notable for the fastest profit growth, 22.90% a year since FY22. Oil India stands out for the strongest latest-quarter profit growth at 96.77%. Sona BLW offers a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.07. Ajanta Pharma brings the highest return on equity at 23.33%. These are watchlist names for accelerating profit stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Ajanta Pharma a good stock for long-term investors?
Ans. Ajanta Pharma has a return on equity of 23.33%, a PE of 36.59 against an industry PE of 36.35 and a market cap of Rs 41,525 crore. Net profit has compounded at 10.33% a year since FY22, and FY26 revenue rose 18.60% while June 2026 quarter net profit grew 30.89%. Long-term returns in accelerating profit stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Federal Bank become a multibagger from here?
Ans. Federal Bank has already gained 259.57% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in accelerating profit stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 22.90% a year since FY22, and FY26 revenue rose 7.00%. At a PE of 15.47 against an industry PE of 11.94, valuation should be checked against that growth before investing.
What is the market cap of Federal Bank, Oil India, Sona BLW and Ajanta Pharma?
Ans. As of 23 October 2026, Federal Bank has a market cap of Rs 83,333 crore, Oil India has a market cap of Rs 72,750 crore, Sona BLW has a market cap of Rs 49,859 crore and Ajanta Pharma has a market cap of Rs 41,525 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on accelerating profit stocks.
What are the risks of investing in accelerating profit stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Sona BLW trades at a PE of 72.68 against an industry PE of 37.33, so earnings growth needs to hold up.
Why is Sona BLW trading at a PE of 72.68?
Ans. Sona BLW’s PE of 72.68 compares with an industry PE of 37.33. The market is paying a premium for profit growth of 14.86% a year since FY22, latest-quarter profit growth of 46.67% and FY26 revenue growth of 24.19%, which also means the stock is more sensitive if growth slows. Investors in accelerating profit stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Federal Bank, Oil India, Sona BLW and Ajanta Pharma?
Ans. As of the latest reported quarter, FII and DII together hold 76.99% of Federal Bank (27.71% and 49.28%), 27.42% of Oil India (7.28% and 20.14%), 65.22% of Sona BLW (23.61% and 41.61%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in accelerating profit stocks, though it should be read with earnings trends rather than on its own.
